The latest capital investing data indicates an uptick in healthcare equities, with the sector index rising 2.3% over five sessions. Hedge fund positioning reveals growing bets on biotech due to FDA fast-track approvals anticipated in late 2024. Ares Capital offers an especially juicy dividend and has trounced the S&P 500's total return since 2004. Joined VanEck in 2024 Prior to VanEck, led the corporate investment team for Circle Ventures BA, International Business & Management, Dickinson College Dividend-paying blue chips are attracting steady capital investing interest, with yields outperforming treasury rates. Market strategists highlight this as a hedge against volatility, supporting portfolio stability.